Mahmood I
Division of Pharmaceutical Evaluation I, Office of Clinical Pharmacology and Biopharmaceutics, Food and Drug Administration, Rockville, Maryland 20852, USA.
J Clin Pharmacol. 2000 Dec;40(12 Pt 2):1439-46.
The objective of this study is to evaluate whether unbound clearance of a drug can be predicted more accurately than total clearance using the allometric approach and if there is any real advantage of predicting unbound clearance over total clearance. The total and unbound clearance of 20 randomly selected drugs were scaled up from the animal data (at least three animal species) obtained from the literature. Three methods were used to generate plots to scale up the clearance values: (1) total or unbound clearance versus body weight (simple allometric equation), (2) the product of total or unbound clearance and maximum life span potential (MLP) versus body weight, and (3) the product of total or unbound clearance and brain weight versus body weight. The results of this study indicate that there will be instances when unbound clearance can be predicted better than total clearance or vice versa. In conclusion, unbound clearance cannot be predicted any better than total clearance.
本研究的目的是评估使用异速生长方法预测药物的非结合清除率是否比总清除率更准确,以及预测非结合清除率相对于总清除率是否具有任何实际优势。从文献中获得的动物数据(至少三种动物物种)按比例放大了20种随机选择药物的总清除率和非结合清除率。使用三种方法生成用于按比例放大清除率值的图:(1)总清除率或非结合清除率与体重(简单异速生长方程),(2)总清除率或非结合清除率与最大寿命潜力(MLP)的乘积与体重,以及(3)总清除率或非结合清除率与脑重的乘积与体重。本研究结果表明,在某些情况下,非结合清除率可能比总清除率预测得更好,反之亦然。总之,非结合清除率的预测并不比总清除率更好。